Prelude Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $48,020 - $55,566	554 Added 3.76%	15,282 $1.32 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $5,615 - $7,505	64 Added 0.44%	14,728 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $894,438 - $1.2 Million	11,052 Added 305.98%	14,664 $1.52 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $506,927 - $598,119	-6,170 Reduced 63.08%	3,612 $306,000
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $699,217 - $849,566	9,782 New	9,782 $811,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $530,956 - $644,352	-7,105 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $212,602 - $264,105	2,928 Added 70.1%	7,105 $623,000
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $96,175 - $150,181	1,209 Added 40.73%	4,177 $515,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $483,317 - $655,868	-6,772 Reduced 69.53%	2,968 $251,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $620,655 - $834,075	9,657 Added 11634.94%	9,740 $824,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $778,470 - $983,020	-11,550 Reduced 99.29%	83 $6,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $545,335 - $637,299	6,787 Added 140.05%	11,633 $996,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $101,040 - $118,344	1,200 Added 32.91%	4,846 $430,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $279,768 - $370,290	-3,491 Reduced 48.91%	3,646 $310,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $259,031 - $291,575	2,758 Added 62.98%	7,137 $692,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $7,220 - $9,407	95 Added 2.22%	4,379 $413,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $462,291 - $551,333	-5,952 Reduced 58.15%	4,284 $347,000
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $625,243 - $736,496	7,742 Added 310.43%	10,236 $913,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $201,016 - $236,805	2,494	2,494 $232,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.53 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.3 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.27 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$936 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$707 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account